ADHD Evaluation and Treatment Protocol
Follow the American Academy of Pediatrics (AAP) 2019 guideline algorithm: initiate evaluation for any child age 4-18 years presenting with academic/behavioral problems and symptoms of inattention, hyperactivity, or impulsivity, confirm diagnosis using DSM-5 criteria with multi-informant reports, screen for comorbidities, then implement age-specific treatment protocols. 1
Diagnostic Evaluation Protocol
Step 1: Initial Assessment
- Trigger for evaluation: Academic or behavioral problems PLUS symptoms of inattention, hyperactivity, or impulsivity in children ages 4-18 years 1
- Not recommended: Children under 4 years (insufficient evidence for diagnosis/treatment except parent training) 1
Step 2: Confirm DSM-5 Diagnostic Criteria
You must document ALL of the following 1:
- Specific DSM-5 symptom criteria met (inattentive, hyperactive-impulsive, or combined presentation)
- Impairment in MORE than 1 major setting (home, school, social)
- Information obtained from multiple sources: parents/guardians, teachers, school personnel, mental health clinicians
- Alternative causes ruled out
Key point: Use DSM-based ADHD rating scales with normative data. Neuropsychological testing does NOT improve diagnostic accuracy in most cases but may clarify learning strengths/weaknesses 1
Step 3: Screen for Comorbid Conditions (Grade A Recommendation)
Mandatory screening for 1:
- Emotional/behavioral: Anxiety, depression, oppositional defiant disorder, conduct disorder, substance use
- Developmental: Learning disorders, language disorders, autism spectrum disorder
- Physical: Tics, sleep apnea
Critical caveat: Comorbidities occur in approximately 80% of adults with ADHD and are common in children; failure to identify these leads to treatment failure 2
Treatment Protocol by Age
Preschool-Aged Children (4-5 years) - Grade A
First-line treatment: Evidence-based parent training in behavior management (PTBM) and/or behavioral classroom interventions 1
Second-line (if behavioral interventions fail): Methylphenidate may be considered ONLY if:
- Behavioral interventions provide insufficient improvement AND
- Moderate-to-severe continued functional disturbance present 1
Important: Weigh risks of early medication against harm of delaying treatment when behavioral interventions unavailable 3
Elementary/Middle School Children (6-11 years) - Grade A
Prescribe BOTH 1:
- FDA-approved ADHD medications (Grade A - strong recommendation)
- PTBM and/or behavioral classroom interventions (preferably both - Grade B)
Medication hierarchy by evidence strength 3:
- Strongest: Stimulant medications (methylphenidate, dextroamphetamine)
- Sufficient but less strong: Atomoxetine
- Sufficient but weaker: Extended-release guanfacine
- Weakest of approved: Extended-release clonidine
Adolescents (12-18 years) - Grade A
Prescribe FDA-approved medications WITH adolescent's assent 1
May add: Behavioral therapy (Grade C recommendation - weaker evidence than younger ages) 3
Preferably both medication and behavioral therapy 3
Medication Management Protocol
Titration Strategy (Grade B - Strong Recommendation)
Titrate doses to achieve maximum benefit with minimum adverse effects 1, 3
- Individual response varies; one child may respond better to one stimulant than another 4
- May require dosing adjustments: before breakfast, before lunch, and afternoon 4
- Monitor for adverse events (medications associated with adverse events per recent 2024 systematic review) 5
Combination Therapy Evidence
Important finding: Combination of medication with youth-directed psychosocial interventions does NOT systematically produce better results than monotherapy, though few combinations have been evaluated 5
Chronic Disease Management Approach (Grade B)
Treat ADHD as a chronic condition following chronic care model and medical home principles 1, 3:
- Frequent reassessment required 6
- Treatment adjustments as needed over time
- Coordinate with schools (IEP or 504 plans are necessary components) 1
- Manage as children/youth with special health care needs 3
Comorbidity Management Protocol
If trained/experienced in diagnosing comorbid conditions: Initiate treatment or refer to subspecialist 1
If NOT trained/experienced: Refer to appropriate subspecialist for diagnosis and treatment initiation 1
Critical: Educational interventions and individualized instructional supports are necessary parts of ANY treatment plan 1
Common Pitfalls to Avoid
- Failing to obtain multi-informant data - diagnosis requires information from multiple settings 1
- Missing comorbidities - screen systematically; they're present in majority of cases 1
- Inadequate medication titration - must optimize to maximum benefit with tolerable side effects 1
- Treating as acute rather than chronic condition - requires ongoing monitoring and adjustment 3
- Medication-only approach in school-age children - guidelines recommend combined treatment 1